2016•Redalyc (Universidad Autónoma del Estado de México)Requires access

Volume Response to a Bronchodilator in Patients with COPD

Jimena Falco, Vanina Martín, Leandro Marozzi, Marco Antonio Solis Aramayo, Marcos Hernández, Edgardo M. Sobrino, Sílvia Quadrelli

Open publisher page 2 citations

Abstract

"The chronic obstructive pulmonary disease (COPD) is characterized by persistent airflow limitation. It is a frequent, known and treatable disease. The diagnosis requires tobacco smoking personal history or expositional history and evidence of an obstructive pattern at the spirometry measured before and after bronchodilators. The degree of reversibility of airflow differs between patients, and does not predict the response to bronchodilator therapy. It can be seen in terms of forced vital capacity or forced expiratory flow, depending on the severity of the disease. This paper presents the differences in bronchodilator response in terms of measurements of the flow and the volume in patients diagnosed with COPD at different stages of GOLD. The bronchodilator response and its relationship to the severity of the disease were analized."

About this research paper

What this paper is about

"The chronic obstructive pulmonary disease (COPD) is characterized by persistent airflow limitation. It is a frequent, known and treatable disease. The diagnosis requires tobacco smoking personal history or expositional history and evidence of an obstructive pattern at the spirometry measured before and after bronchodilators. The degree of reversibility of airflow differs between patients, and does not predict the response to bronchodilator therapy. It can be seen in terms of forced vital capacity or forced expiratory flow, depending on the severity of the disease. This paper presents the differences in bronchodilator response in terms of measurements of the flow and the volume in patients diagnosed with COPD at different stages of GOLD. The bronchodilator response and its relationship to the severity of the disease were analized."

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

"The chronic obstructive pulmonary disease (COPD) is characterized by persistent airflow limitation. It is a frequent, known and treatable disease. The diagnosis requires tobacco smoking personal history or expositional history and evidence of an obstructive pattern at the spirometry measured before and after bronchodilators. The degree of reversibility of airflow differs between patients, and does not predict the response to bronchodilator therapy. It can be seen in terms of forced vital capacity or forced expiratory flow, depending on the severity of the disease. This paper presents the differences in bronchodilator response in terms of measurements of the flow and the volume in patients diagnosed with COPD at different stages of GOLD. The bronchodilator response and its relationship to the severity of the disease were analized."

Key concepts: Bronchodilator, COPD, Medicine, Spirometry, Bronchodilator Agents, Vital capacity, Pulmonary disease, Cardiology

Related papers

Back to paper searchBrowse research topicsOriginal source
Volume Response to a Bronchodilator in Patients with COPD — Research Paper | ScholarLens